Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 27.48 Delayed Data As of Jun 09 |  -0.91 / -3.21%Today’s Change | 11.70 Today|||52-Week Range 33.80 | +62.03% Year-to-Date |
Latest ARCT News | Press Releases
No recent news for Arcturus Therapeutics Holdings Inc.
Today’s Trading
| Previous close | 28.39 |
| Today’s open | 28.62 |
| Day’s range | 27.31 - 28.80 |
| Volume | 10,131 |
| Average volume (3 months) | 461,345 |
| Market cap | $713.0M |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -502.55% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +1,566.79% |
| P/E ratio | 6.6 |
| Price/Sales | 2.23 |
| Price/Book | 2.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMRXAmneal Pharmaceutica... | +0.04 | +1.67% |
| COLLCollegium Pharmaceut... | -0.16 | -0.73% |
| ---- | ||
| LXRXLexicon Pharmaceutic... | -0.21 | -6.93% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $206.0M |
| Annual profit (last year) | $9.3M |
| Net profit margin | 4.54% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
